2021
DOI: 10.1016/j.yebeh.2021.107957
|View full text |Cite
|
Sign up to set email alerts
|

Stereoelectroencephalography-guided radiofrequency thermocoagulation for hypothalamic hamartoma: Electroclinical patterns and the relationship with surgical prognosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 31 publications
0
4
0
Order By: Relevance
“…1 Strategy A: Less than five electrodes were implanted only within the target of HH, mainly for SEEG-guided RFTC by the same recording electrodes. This strategy was applied to the HH cases with a typical history of GS, and the size of the lesion was deemed suitable for RFTC ( 17 ).…”
Section: Methodsmentioning
confidence: 99%
“…1 Strategy A: Less than five electrodes were implanted only within the target of HH, mainly for SEEG-guided RFTC by the same recording electrodes. This strategy was applied to the HH cases with a typical history of GS, and the size of the lesion was deemed suitable for RFTC ( 17 ).…”
Section: Methodsmentioning
confidence: 99%
“…A trend toward association with seizure outcome was also recorded for patients with type 2 HH, in line with other series, 2 due to the purely intraventricular location. Type 2 was the most frequently treated type of HH, as reported in other series using ES, LITT or RF‐THC 3,10,12 ; type I and type III were more frequently reported in microsurgical series 13,14 and this aspect might reflect a selection bias. Based on the surgical outcome of our report, ES or LITT can be proposed as a first stage treatment for HH‐related epilepsy also in non‐type II HH, without excluding microsurgery after one or more failure of the so‐called “minimally invasive techniques.” Moreover, RF‐TC could represent a valid alternative to expensive techniques, especially in low‐income countries 10 .…”
Section: Discussionmentioning
confidence: 65%
“…Prior systematic reviews and meta-analyses [41] have illustrated the efficacy of SgRFTC in focal, anatomically-limited epilepsies. Particular etiologic examples include hypothalamic hamartomas [42][43][44][45][46], hippocampal sclerosis [39], focal cortical dysplasias [34,[47][48][49], and periventricular heterotopias [35,42,50]. While current reported treatment outcomes are quite good, reaching up to 60% Engel 1 status [41], novel methodologies and applications may not only improve seizure freedom rates but also widen the scope of treatment.…”
Section: Future Of Sgrftcmentioning
confidence: 99%